Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 9, 2004, Pages 1022-1027

  Koechlin, Christelle ^a   Couillard, Annabelle ^b   Simar, David ^b   Cristol, Jean Paul ^b   Bellet, Hélène ^b   Hayot, Maurice ^b   Prefaut, Christian ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b NONE

Author keywords

Antioxidant; Endurance; N acetylcysteine; Placebo; Superoxide anion

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; PLACEBO; PROTEIN; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; LIPID PEROXIDATION; MALE; MUSCLE EXERCISE; MUSCLE MASS; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VENOUS BLOOD;

EID: 2142702297     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200310-1465oc     Document Type: Article

References (41)

1. 2 therapy. J Appl Physiol 1996;81:2199-2202.
2. Heunks LM, Vina J, van Herwaarden CL, Folgering HT, Gimeno A, Dekhuijzen PN. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999;277:R1697-R1704.
3. Couillard A, Koechlin C, Cristol JP, Varray A, Préfaut C. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J 2002;20:1123-1129.
4. Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C, Leblanc P, Préfaut C. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1664-1669.
5. Barreiro E, Gea J, Corominas JM, Hussein SBN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003;29:771-778.
6. Langen RCJ, Kom SH, Wouters EFM. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 2003;35:226-235.
7. Davies KJ, Quintanillia AT, Brooks GA, Packer L. Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 1982;107:1198-2005.
8. Reid MB. Muscle fatigue: mechanisms and regulation. In: Sen CK, Packer L, Hanninen O, editors. Handbook of oxidants and antioxidants in exercise. Amsterdam: Elsevier, 2000. p. 599-629.
9. American Thoracic Society and European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159(Suppl.):S1-S40.
10. Saey D, Debigare R, LeBlanc P, Mador MJ, Cote CH, Jobin J, Maltais F. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:425-430.
11. Mador MJ, Deniz O, Aggarwal A, Kufel TJ. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:102-108.
12. Kelly GS. Clinical applications of N-acetylcysteine. Altern Med Rev 1998;3:114-127.
13. Engelen MPKJ, Schols AMWJ, Does JD, Deutz NEP, Wouters EFM. Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. Am J Respir Crit Care Med 2000;161:98-103.
14. Rabinovich RA, Ardite E, Trooster T, Carbo N, Alonso J, Gonzales de Suzo J, Vilaro J, Barbera J, Figueras Paob M, Argiles JM, et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1114-1118.
15. Bridgeman M, Marsden M, Selby C. Effect of N-acetylcysteine on the concentrations of thiols in plasma bronchoalveolar lavage fluid and lining tissue. Thorax 1994;49:670-675.
16. Andersen P, Adams R, Sjogaard G, Thorboe A, Saltin B. Dynamic knee extension as model for study of isolated exercising muscle in humans. J Appl Physiol 1985;59:1647-1653.
17. Koechlin C, Couillard A, Simar D, Chanez P, Bellet H, Cristol JP, Préfaut C. Is oxidative stress implicated in reduced exercise tolerance in chronic obstructive pulmonary disease [abstract]? Am J Respir Crit Care Med 2003;167:A28.
18. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global initiative for chronic obstructive lung disease: GOLD Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
19. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003;22:1-2.
20. Serres I, Gauthier V, Varray A, Prefaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 1998;113:900-905.
21. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212-216.
22. Witko-Sarsat V, Friedlander M, Khoa TN, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B. Advanced oxidation protein products as novels mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161:2524-2532.
23. Vachier I, Chanez P, Le Doucen C, Damon M, Descomps B, Godard P. Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur Respir J 1994;7:1585-1592.
24. Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994;234:279-293.
25. Han D, Loukianoff S, McLaughlin L. Oxidative stress indices: analytical aspects and significance. In: Sen CK, Packer L, Hanninen O, editors. Handbook of oxidants and antioxidants in exercise. Amsterdam: Elsevier; 2000, p. 433-483.
26. Cachia O, Leger C, Boulot P. Red blood cell vitamin E concentrations in fetuses are related to but lower than those in mothers during gestation: a possible association with maternal lipoprotein plasma level. Am J Obstet Gynecol 1995; 173: 42-51.
27. Holdiness MR. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 1991;20:123-134.
28. Serres I, Varray A, Vallet G, Micallef JP, Prefaut C. Improved skeletal muscle performance after individualised exercise training in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 1997;4:232-238.
29. Haliwell B, Chirico S. Lipid peroxidation: its mechanism measurement and significance. Am J Clin Nutr 1993;57:715-724.
30. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein product in patients with coronary artery disease. Atherosclerosis 2002;162:221-225.
31. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, Delcourt C, Papoz L, Descomps B, Canaud B. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002;17:422-427.
32. Grandjean EM, Berthet P, Ruffmann R, Leunberger P. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther 2000;22:209-221.
33. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-634.
34. Marquis K, Debigaré R, Lacasse Y, Leblanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-813.
35. Mador JM. Musde mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;166:787-789.
36. McNee W, Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:S58-S65.
37. Boots AW, Haenen GRMM, Bast A. Oxidant metabolism in chronic obstructive pulmonary disease. Eur Respir J 2003;22:14S-27S.
38. Janiszewski M, Pedro MA, Scheffer RC, Van Asseldonk JH, Souza LC, Da Luz PL, Augusto O, Laurindo FR. Inhibition of vascular NADH/NADPH oxidase activity by thiol reagents: lack of correlation with cellular glutathione redox status. Free Radic Biol Med 2000;29:889-899.
39. Agustí AGN, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-360.
40. Oudijk EJD, Lammers JWJ, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J 2003;22:5S-13S.
41. Reid MB, Stokie DS, Koch SM, Khawli FA, Leis AA. N-acetylcysteine inhibits muscle fatigue in humans. J Clin Invest 1994;94:2468-2474.